Clinical Trials in Boston

Showing 581-600 of 17,836 trials

Boston Medical Center Ultrasound Decongestion Study in Heart Failure

NCT07096726

The purpose of this study is to analyze the utility of a novel five-point ultrasound as a predictor of volume overload in diverse patients who are admitted with volume overload/congestive heart failure (CHF) exacerbation at Boston Medical Center (BMC), the largest safety-net hospital in New England. Current standard of care (SOC) involves the utilization of laboratory markers and physical exam, which is often inconsistent and equivocal. The investigators will assess will assess if ultrasound-assisted diuresis reduces recurrent episodes of volume overload/decompensated heart failure.

Congestive Heart FailureVolume Overload

Boston Medical Center200 participantsStarted Jun 2026

Boston, Massachusetts, United States

Not Yet RecruitingNA< 1 mile

ACTIVATE: AI-driven Clinical-trial Trial-Information and Viability Assessment Tool for EHRs

NCT07232043

This study aims to develop and evaluate ACTIVATE, an AI-driven tool for clinical trial information and viability assessment using electronic health records (EHRs). The project will leverage retrospective and prospective EHR data to build and validate algorithms that identify potentially eligible participants for clinical trials and facilitate trial matching.

Cancer

Dana-Farber Cancer Institute70,000 participantsStarted Jun 2026

Boston, Massachusetts, United States

Boston Medical Center Ultrasound Decongestion Study in Heart Failure

ACTIVATE: AI-driven Clinical-trial Trial-Information and Viability Assessment Tool for EHRs

Find Trials by Condition in Boston

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

DS-3201b in Participants With Lymphomas

Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)

A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care

Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC

The PROMISE Pediatric Study 6 to 11 Years Old

A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR)

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.

Development of Adaptive Deep Brain Stimulation for OCD

Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer

A Study to Learn About How a New Pneumococcal Vaccine Works in Infants

Digital Bonding vs. Direct Bonding Study

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia

A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis

Comparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple Sclerosis